Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 895, pseudogene (RNU6-895P)
- Target
- RNU6-895P
- Molecular classification
- Pseudogene, Non-coding RNA, Small nuclear RNA-derived pseudogene
01
Overview
RNA, U6 small nuclear 895, pseudogene (RNU6-895P) is a non-protein-coding RNA gene classified as a pseudogene derived from the U6 small nuclear RNA gene family[5]. While U6 snRNA plays a critical role in the splicing of pre-mRNA as part of the spliceosome in eukaryotic cells[1][3], the "895" pseudogene variant is not functional for splicing and does not produce a functional snRNA or protein product. Pseudogenes such as RNU6-895P may act as genomic "relics" and sometimes participate in regulatory non-coding RNA activities, but there is no evidence that RNU6-895P itself acts in these capacities. It is not associated with any known drug interactions, validated disease roles, or biomarker use, and it is not considered a therapeutic target[5][4].
- Other names
- RNU6-895PU6 small nuclear RNA 895, pseudogene
02
Mechanism of action
None known or reported
03
Biological functions
None established specifically for RNU6-895PPotential generic pseudogene functions (e.g., acting as a microRNA decoy, lncRNA, or RNA interference regulator), but not known or reported for this specific locus
04
Disease associations
None established for RNU6-895PPseudogenes in general can be involved in cancer, regulation of parental gene expression, or act as competitive endogenous RNAs, but no data specifically for RNU6-895P
Beyond the preview
Go deeper on RNA, U6 small nuclear 895, pseudogene (RNU6-895P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 895, pseudogene (RNU6-895P).